Switzerland tightens guidelines for devices on loan
This article was originally published in Clinica
A written contractual agreement between hospitals and organisations that hire out specific surgical instruments in Switzerland could greatly reduce the risk of infection. This is the main thrust of the advice attached to new guidelines laid down by the Swiss Agency for Therapeutic products, Swissmedic. The biggest problem is that hospitals often cannot carry out to the highest possible standard procedures connected with the washing, disinfecting or sterilising of instruments for their reuse.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.